Artificial Intelligence In Precision Medicine Is Fastest Growing Segment Fueling Growth Of Artificial Intelligence In Digital Genome Market
![]() |
| Artificial Intelligence In the Digital Genome Market |
The global Artificial Intelligence In Digital Genome Market is estimated to be valued at US$ 565.69 Mn in 2023 and is expected to exhibit a CAGR of 44.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Artificial Intelligence in Digital Genome refers to the application of AI
techniques to analyze large amounts of genomic and associated patient data to
discover new treatments for various diseases. It helps analyze huge amounts of
genomic data in a fraction of time required by humans to identify meaningful
correlations that can accelerate development of precision medicines.
Market key trends:
One of the major trends in the Artificial Intelligence In Digital Genome Market
is growing investments from key players to develop products and platforms for
advanced genome analysis. For instance, in 2021, Fabric Genomics Inc. which
develops an AI-powered platform for genomic data analysis, raised $80 million
in series B funding round led by Khosla Ventures and Addition. Similarly, Verge
Genomics which offers an AI-powered platform to analyze and interpret genomic
data, raised $90 million in Series C funding to accelerate product development.
This trend is expected to continue as more players enter the market and focus
on utilizing AI to unleash the potential of genomic data for precision medicine
applications.
Segment Analysis
The global artificial intelligence in digital genome market is segmented based
on offering, technology, application, end-user, and geography. Based on
offering, the market is bifurcated into software and services. The services
segment dominated the market in 2022 and is projected to register the highest
CAGR over the forecast period owing to the continuous demand for consulting,
integration, and support services for genomic data storage and analysis.
By technology, the market is categorized into machine learning and deep
learning, natural language processing, and others. The machine learning and
deep learning segment accounted for the largest share of the market in 2022 due
to its wide applications in precision medicine, drug discovery, biomarker
development, and medical imaging.
Based on application, the market is classified into precision medicine, drug
discovery & repurposing, agricultural & veterinary, and cell therapy.
The precision medicine segment dominated the market in 2022 as AI tools help
analyze the genomic data of various diseases along with patient's electronic
health records. This customized treatment aids in better diagnosis and
prognosis.
Key Takeaways
The global Artificial Intelligence In Digital Genome Market Size was valued at
US$ 565.69 Mn in 2023 and is expected to reach US$ 8,137.23 Mn by 2030,
expanding at a formidable CAGR of 44% during the forecast period. The
burgeoning demand for precision medicine and integration of AI with genomic
data is catalyzing market growth.
On the regional front, North America captured the largest market share in 2023
driven by the presence of prominent AI technology providers and genomic testing
companies in the US and Canada. Furthermore, increasing R&D investments by
government and private organizations are fueling technological advancements.
Europe occupied the second position in terms of revenue backed by rising
healthcare expenditure and growing adoption of personalized medicine in
countries like Germany, the UK, and France. Asia Pacific is anticipated to
witness the fastest growth over the forecast period propelled by improving
diagnostics infrastructure and expanding patient pool in China, India, and
Japan.
Key players operating in the artificial intelligence in digital genome market
include NVIDIA Corporation, IBM, Microsoft, Fabric Genomics Inc., Verge
Genomics, MolecularMatch Inc., SOPHiA GENETICS, PrecisionLife Ltd,
BenevolentAI, and Deep Genomics. These companies are focusing on new product
launches, partnerships, and acquisitions to strengthen their market position.

Comments
Post a Comment